Primary Health Properties PLC Director/PDMR Shareholding

RNS Number : 8826F

Primary Health Properties PLC

07 March 2024

 

Primary Health Properties PLC

("PHP" or the "Company"),

 

 

Director/PDMR shareholding

 

The Company has today been notified that the following information relating to the transaction detailed below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation

 

1	Details of the person discharging managerial responsibilities/persons closely associated
(a)	Name	Mark Davies
2	Reason for notification
(a)	Position/Status	Chief Executive Officer, Designate
(b)	Initial notification/amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)	Name	Primary Health Properties PLC
(b)	LEI	213800Y5CJHXOATK7X11
4	Details of the transaction(s): section to be repeated for: (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument and identification code	Ordinary shares of 12.5p ISIN: GB00BYRJ5J14
(b)	Nature of transaction	Purchase
(c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£0.924	100,000
(d)	Aggregated Information Aggregated volume price	Single transaction £92,400
(e)	Date of transaction	6 March 2024
(f)	Place of transaction	London Stock Exchange (XLON)

 

For further information:

 

 

Primary Health Properties PLC

Toby Newman, Company Secretary & Chief Legal Officer

[phone]

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHBLGDXBUGDGSL